From HIV diagnosis to treatment: evaluation of a referral system to promote and monitor access to antiretroviral therapy in rural Tanzania
6
Citation
20
Reference
10
Related Paper
Citation Trend
Abstract:
Background: Individuals diagnosed with HIV in developing countries are not always successfully linked to onward treatment services, resulting in missed opportunities for timely initiation of antiretroviral therapy, or prophylaxis for opportunistic infections.In collaboration with local stakeholders, we designed and assessed a referral system to link persons diagnosed at a voluntary counselling and testing (VCT) clinic in a rural district in northern Tanzania with a government-run HIV treatment clinic in a nearby city.Methods: Two-part referral forms, with unique matching numbers on each side were implemented to facilitate access to the HIV clinic, and were subsequently reconciled to monitor the proportion of diagnosed clients who registered for these services, stratified by sex and referral period.Delays between referral and registration at the HIV clinic were calculated, and lists of non-attendees were generated to facilitate tracing among those who had given prior consent for follow up.Transportation allowances and a "community escort" from a local home-based care organization were introduced for patients attending the HIV clinic, with supportive counselling services provided by the VCT counsellors and home-based care volunteers.Focus group discussions and in-depth interviews were conducted with health care workers and patients to assess the acceptability of the referral procedures.Results: Referral uptake at the HIV clinic averaged 72% among men and 66% among women during the first three years of the national antiretroviral therapy (ART) programme, and gradually increased following the introduction of the transportation allowances and community escorts, but declined following a national VCT campaign.Most patients reported that the referral system facilitated their arrival at the HIV clinic, but expressed a desire for HIV treatment services to be in closer proximity to their homes.The referral forms proved to be an efficient and accepted method for assessing the effectiveness of the VCT clinic as an entry point for ART. Conclusion:The referral system reduced delays in seeking care, and enabled the monitoring of access to HIV treatment among diagnosed persons.Similar systems to monitor referral uptake and linkages between HIV services could be readily implemented in other settings.Keywords:
Antiretroviral treatment
The effectiveness of an antiretroviral (ARV) treatment and a highly active antiretroviral therapy (HAART) on the epidemic model of HIV/AIDS is investigated. We apply the theory of optimal control where an antiretroviral (ARV) treatment and a highly active antiretroviral therapy (HAART) are used as control strategies in order to prevent the spread of HIV/AIDS. We apply Pontryagin's Maximum Principle to get the optimal system. Numerical simulations are conducted to support the analytical solution so that the effectiveness of an antiretroviral (ARV) treatment and a highly active antiretroviral therapy (HAART) can be shown.
Antiretroviral treatment
Pontryagin's minimum principle
Cite
Citations (4)
The natural course of mostly perinatally acquired childhood HIV infection shows some special characteristics. Compared to adults the initial viral load is higher, persists for a longer period of time and without antiretroviral therapy up to 20% of infected children develop AIDS within the first year of life. It is therefore desirable to stop disease progression before an irreversible deterioration of the immune system has occurred by initiating early antiretroviral therapy. The choice of antiretroviral agents is difficult because data from adult studies cannot be directly applied to infants and data on antiretroviral therapy in pediatric patients are limited. The current national and international guidelines for antiretroviral therapy in perinatally acquired HIV infection are discussed.
Antiretroviral treatment
ANTIRETROVIRAL AGENTS
Cite
Citations (1)
Cite
Citations (0)
Background: Human immunodeficiency virus attacks CD4 cells primarily. Current CD4 count is a strong predictor of the immediate risk of acquired immune deficiency syndrome or death. Antiretroviral therapy results in an improvement in immunologic status, one feature of which is an increase in the CD4 cell count.Objectives: To study the effect of Antiretroviral therapy on CD4 cell count & WHO staging among people living with HIV/AIDS.Methodology: A retrospective cross-sectional descriptive study was conducted using data available from Antiretroviral therapy centre attached to Teaching Hospital of Karwar Institute of Medical Sciences, Karwar.Conclusion: Antiretroviral therapy among People Living with HIV was significantly associated with the increase in their CD4 cell count. The mean difference of the CD4 count increase in patients obtained was of 451 and is statistically significant (P < 0.01). There is improvement in the WHO staging of the disease after the start of Antiretroviral therapy
Antiretroviral treatment
Tertiary care
Cite
Citations (0)
Abstract This chapter begins with a recollection of the early days of HIV and AIDS, prior to the advent of highly active antiretroviral therapy (HAART). It chronicles the so-called ‘dark ages’ of HIV/AIDS treatment, which focused on the treatment of patients with chemical agents already in use. It describes the advent and evolution of HAART and its extension of and enhancement of life with HIV.
Antiretroviral treatment
Cite
Citations (1)
Introduction: Mozambique antiretroviral therapy is a database used to monitor patients receiving antiretroviral treatment (ART). This study's objective was to evaluate the system for the purpose to monitor patients receiving ART.
Antiretroviral treatment
Cite
Citations (3)
Mitochondrial toxicity
Liver disease
Etiology
Hepatitis B
Cite
Citations (0)
Antiretroviral treatment
Cite
Citations (0)
Antiretroviral treatment
Cite
Citations (4)
Scheduled treatment interruptions are preplanned interruptions of antiretroviral treatment, which may be directed by time (e.g., cycles of 8 weeks on treatment and 8 weeks off treatment); the concentration of CD4+ lymphocytes (the CD4 count); HIV-1 RNA concentration (viral load); or other factors. This review covers the rationale of scheduled treatment interruptions and the different strategies that have been explored. It examines the issue of autovaccination, resistance and other risks and benefits. Scheduled-treatment-interruption studies in three populations are discussed: patients who initiated highly active antiretroviral therapy during acute HIV infection; patients with successfully treated chronic HIV infection; and patients with highly active antiretroviral therapy failure.
Antiretroviral treatment
ANTIRETROVIRAL AGENTS
Drug holiday
Cite
Citations (8)